Skip to Content

Zartra

Active Substance: imiquimod
Common Name: imiquimod
ATC Code: L03AX
Marketing Authorisation Holder: Laboratoires 3M Santé
Active Substance: imiquimod
Status: Withdrawn
Authorisation Date: 1998-09-18
Therapeutic Area: Condylomata Acuminata
Pharmacotherapeutic Group: Immunostimulants

Therapeutic Indication

Imiquimod cream is indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients.

The marketing authorisation for Zartra has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide